NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan.
$435M Series B+ ·
Led by Founders Fund · Source: x.com
Total raised: $650M across 4 sourced rounds
All 4 rounds ↓Signals
About NewLimit
We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit | 580 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $435M | x.com | ||
| Series B+ | $45M | — | blog.newlimit.com | |
| Series B+ | $130M | blog.newlimit.com | ||
| Series A | $40M | — | techcrunch.com |
Timeline
- X account created
- Website created
Founders and team
JK
Jacob Kimmel Co-founder & CEO@jacobkimmel · source: newlimit.comBB
Blake Byers Co-founderBA
Brian Armstrong Co-founderGJ
Greg Johnson Co-Founder & Head of Machine Learning
Investors
AAbstract Ventures
BBoost VCaccelerator
BBrian Armstrong
DDimension
DDuke Capital Partners
EEli Lilly
FFounders Fundlead investor
GGreenoaks
HHuman Capital
HHuman Ventures
KKhosla Ventures
KKleiner Perkinslead investor
NNFDG Ventures
QQuiet Capital
SSection 32TThrive Capital
VValor Equity Partners
Companies like NewLimit
FFive Alarm BioSeed · Feb 2023VVera GeneticsSeed · May 2026
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
BBreye Therapeutics$76.65M Series A · Sep 2026
IImmorta BioSeed · Oct 2026
AAddition Therapeutics$100M Series A · Dec 2025
Other companies backed by Founders Fund
GGeneral Translation$27M Series A · Nov 2026
OOnodrim$300M Series A · Nov 2026
NNominal$240M Series B+ · Nov 2026
NNorthwood$375M Series B+ · Nov 2026
EErebor$30M · Oct 2026
WWatchtower Labs$35M Seed · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/newlimit (get a free API key).